Results 171 to 180 of about 10,088 (188)

Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder

Vaccine, 2018
Liquid vaccine dosage forms have limited stability and require refrigeration during their manufacture, distribution and storage. In contrast, solid vaccine dosage forms, produced by for example spray drying, offer improved storage stability and reduced dependence on cold-chain facilities.
Thakur, Aneesh, Ingvarsson, Pall Thor, Schmidt, Signe Tandrup, Rose, Fabrice, Andersen, Peter, Christensen, Dennis, Foged, Camilla   +6 more
openaire   +3 more sources

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

Vaccine, 2015
H56:IC31 is a candidate tuberculosis vaccine comprising a fusion protein of Ag85B, ESAT-6 and Rv2660c, formulated in IC31 adjuvant. This first-in-human, open label phase I trial assessed the safety and immunogenicity of H56:IC31 in healthy adults without or with Mycobacterium tuberculosis (M.tb) infection.Low dose (15 μg H56 protein in 500 nmol IC31 ...
Angelique Kany Kany, Luabeya, Benjamin M N, Kagina, Michele D, Tameris, Hennie, Geldenhuys, Soren T, Hoff, Zhongkai, Shi, Ingrid, Kromann, Mark, Hatherill, Hassan, Mahomed, Willem A, Hanekom, Peter, Andersen, Thomas J, Scriba, Elisma, Schoeman, Colleen, Krohn, Cheryl L, Day, Hadn, Africa, Lebohang, Makhethe, Erica, Smit, Yolande, Brown, Sara, Suliman, E Jane, Hughes, Peter, Bang, Margaret A, Snowden, Bruce, McClain, Gregory D, Hussey   +24 more
openaire   +2 more sources

TWO NEW ESCHERICHIA COLI O ANTIGENS, O162 AND O163, AND ONE NEW H ANTIGEN, H56. WITHDRAWAL OF H ANTIGEN H50

Acta Pathologica Microbiologica Scandinavica Section B Microbiology, 1975
Three E. coli strains representing strains from faeces of normal persons were established as antigenic test strains of two new O antigens, O162 and O163, and one new H antigen, H56.
I, ørskov, F, ørskov, K A, Bettelheim, M E, Chandler   +3 more
openaire   +2 more sources

Structure of the O-polysaccharide of Yersinia frederiksenii H56-36/81 (serotype O:60) containing 4-deoxy-d-arabino-hexose

Russian Chemical Bulletin, 2016
Aiming at creation of the chemical basis for serotyping of strains of Yersinia spp., we studied the O-specific polysaccharide (OPS) of Yersinia frederiksenii H56-36/81 belonging to serotype O:60. A branched polysaccharide was obtained by mild alkaline degradation of the lipopolysaccharide (LPS) isolated from bacterial cells by the phenol—water ...
O. V. Sizova, A. S. Shashkov, R. Z. Shaikhutdinova, S. A. Ivanov, S. V. Dentovskaya, Yu. A. Knirel   +5 more
openaire   +1 more source

Comparison ofβ-Adrenergic blocking activity of DCI, H56/28, ICI50172, LB46, methoxamine, MJ 1999 and propranolol in the blood perfused canine papillary muscle preparation

Experientia, 1970
Nachweis, dass derβ-Blocker LB46 am blutperfundierten Papillarmuskel des Hundes eine grossere Aktivitat aufweist als 6 andere bekannteβ-Blocker.
K, Hashimoto, M, Endoh, K, Tamura, N, Taira   +3 more
openaire   +2 more sources

MPEC 2024-H56 : 2024 HZ

The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements. They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
openaire   +1 more source

MPEC 2025-H56 : 2016 CP433

The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements. They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
openaire   +1 more source

Cases from the aerospace medicine residents' teaching file. Case H56. Pilot incapacitation of psychiatric etiology (PIPE)

Aviation, space, and environmental medicine, 1994
A case is presented which involves a fighter pilot with anxiety disorder and in-flight panic attacks. The initial presentation, clinical course, evaluation, and aeromedical disposition are all discussed.
L M, Johnson, F E, Carpenter
openaire   +1 more source

Comparison of Β-Adrenergic blocking activity of dichloroisoprenaline (H 56/28, I.C.I. 50172, LB46), methoxamine (MJ 1999) and propranolol in the canine femoral vascular bed

Experientia, 1969
Die blockierende Wirkung intra- arteriell verabreichter,Β-adrenergischer Mittel wurde am femoralen Gefassgebiet des Hundes untersucht. DCI, H 56/28 und LB 46 per se regten den arteriellen Blutstrom mit zunehmender Dosierung an, wahrend Methoxamin in umgekehrter Weise wirkte. Eine hemmende Wirkung auf den durch Isoprenalin angeregten Blutstrom fand sich
K, Hashimoto, S, Matsumura, N, Sano, N, Taira   +3 more
openaire   +2 more sources

Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial

The Journal of Infectious Diseases
Abstract Background H56:IC31 is a candidate vaccine against tuberculosis (TB) with the potential to reduce TB recurrence rate. It is thus important for future clinical trials to demonstrate safety and immunogenicity of H56:IC31 in individuals treated for TB.
Dereck Tait, Andreas Diacon, Álvaro H Borges, Elana van Brakel, David Hokey, Kathryn T Rutkowski, Devin J Hunt, Marisa Russell, Peter L Andersen, Ingrid Kromann, Morten Ruhwald, Gavin Churchyard, Rodney Dawson   +12 more
openaire   +3 more sources